Nuvigil launch brings up more questions about whether new forms of existing drugs are better than the original
July 2009
The recent Nuvigil launch brings up more questions about whether new forms of existing drugs are better than the original.
These "follow-on" drugs are the latest trend for drug companies looking to replace drugs with expiring patents.
But these new versions usually don't offer much improvement.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote